Skip to main content
Premium Trial:

Request an Annual Quote

Douglas Rex, Philip Schoenfeld, Deborah Fisher, Scott Ramsey, Fran Tuttle

Premium
Epigenomics has named the first members for its new colorectal cancer medical advisory board. Appointees include Douglas Rex, professor of medicine at Indiana University’s School of Medicine; Philip Schoenfeld, associate professor in the department of internal medicine at the University of Michigan’s School of Medicine; Deborah Fisher, assistant professor of medicine at Duke University; and Scott Ramsey, associate professor of medicine and health services at the Fred Hutchinson Cancer Research Center.
 

 
Fran Tuttle has been appointed to join Xceed Molecular’s board of trustees. Tuttle is president and CEO of HX Diagnostics, and formerly was CEO of Protedyne and senior VP of near patient testing at Bayer Diagnostics. Before that she worked at Chiron Diagnostics.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.